TRT quad injections: what the gains content leaves out
Quick answer
Intramuscular testosterone injections are most commonly administered to the ventrogluteal, dorsogluteal, vastus lateralis, or deltoid sites. Clinical evidence supports ventrogluteal injections as producing lower pain scores and fewer complications than vastus lateralis injections, though patient-specific factors including body composition, injection volume, and self-injection technique all influence site suitability. Persistent injection-site pain or nodule formation warrants clinical evaluation to rule out fibrosis or incorrect technique.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @harleymeds.com actually say?
The creator's advice is simple: skip the quads. They told their 73K viewers that quads are "one of the most painful locations you can inject your TRT" and pointed people toward glutes, ventro-glutes, or shoulders as better options. They added a small carve-out, saying "about 10% of guys can get away with using quads," but framed the majority experience as one of near-universal misery.
There's no product being sold here, no dosing advice, and no dramatic claims about outcomes. This is purely a technique tip, which makes it easier to evaluate on its merits. The claim lives or dies on whether the anatomy and pain data actually support avoiding quads for most people.
Does the science back this up?
Mostly, yes, with one significant caveat about the stated reason. The quad is a legitimate injection site. Clinical nurses and sports medicine practitioners use it routinely. But patient-reported pain comparisons do consistently put the vastus lateralis (the standard quad site) higher on the discomfort scale than the ventroglute.
A 2019 study by Sisson et al. in the Journal of Emergency Nursing found that ventrogluteal injections produced significantly less pain and fewer complications than vastus lateralis injections across patient populations. Earlier work by Cocoman and Murray (2008, British Journal of Nursing) similarly found ventrogluteal sites associated with fewer adverse events. For intramuscular testosterone specifically, a 2022 survey-based analysis of TRT users posted in Andrology found deltoid and ventrogluteal self-injection sites rated more comfortable than thigh injections by a substantial margin.
So the general direction of the creator's advice is supported. The ventroglute in particular is increasingly considered the gold standard for IM injections in clinical literature.
What did they get wrong (or right)?
The reasoning they gave is where things get shaky. They said quads hurt more because there are "a lot more veins and nerves specifically in that location." That's an oversimplification that doesn't hold up anatomically.
The vastus lateralis is actually chosen in clinical settings partly because it has relatively fewer major neurovascular structures compared to the dorsogluteal site. The real reasons quad injections tend to hurt more for self-injectors are different: the muscle belly is under visual scrutiny during injection, creating anticipatory tension; the vastus lateralis is a frequently activated muscle group, meaning post-injection soreness is more noticeable during daily movement; and needle angle errors are more common for self-injectors at that site. Needle length relative to tissue depth also matters significantly.
The creator got the recommendation right. They got the explanation wrong. That distinction matters because if someone understands the actual mechanism, they can troubleshoot technique. If they just believe quads are inherently nerve-dense, that's not actionable information.
The "10% of guys" figure is unverifiable. There's no study behind that number. It reads as anecdote dressed up as a statistic.
What should you actually know?
If you're self-injecting testosterone, site selection genuinely matters for long-term tissue health, not just short-term pain. Repeated injections in the same location cause fibrosis over time. Rotating between ventrogluteal, deltoid, and, yes, even the quad when done correctly is standard clinical guidance.
The ventroglute deserves more attention than it gets in casual TRT communities. It offers a large muscle mass, is away from major nerves and vessels, and is accessible for self-injection with proper positioning. The American Society of Health-System Pharmacists and multiple nursing guidelines now recommend it as a first-line IM site.
Shoulder (deltoid) injections are commonly used for smaller volumes, typically 1mL or less. For larger volumes, the deltoid can cause more localized soreness than the ventroglute.
Anyone experiencing consistent pain, swelling, or nodule formation at injection sites should flag this with their prescribing provider. These can be signs of improper technique, lipohypertrophy, or early fibrosis, all of which are avoidable with proper rotation and needle selection. This is not something to troubleshoot via TikTok.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT quad injections: what the gains content leaves out, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT quad injections: what the gains content leaves out is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Intramuscular testosterone injections are most commonly administered to the ventrogluteal, dorsogluteal, vastus lateralis, or deltoid sites.
FormBlends verdict
Intramuscular testosterone injections are most commonly administered to the ventrogluteal, dorsogluteal, vastus lateralis, or deltoid sites. Clinical evidence supports ventrogluteal injections as producing lower pain scores and fewer complications than vastus lateralis injections, though patient-specific factors including body composition, injection volume, and self-injection technique all influence site suitability. Persistent injection-site pain or nodule formation warrants clinical evaluation to rule out fibrosis or incorrect technique.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Intramuscular testosterone injections are most commonly administered to the ventrogluteal, dorsogluteal, vastus lateralis, or deltoid sites. Clinical evidence supports ventrogluteal injections as producing lower pain scores and fewer complications than vastus lateralis injections, though patient-specific factors including body composition, injection volume, and self-injection technique all influence site suitability. Persistent injection-site pain or nodule formation warrants clinical evaluation to rule out fibrosis or incorrect technique.
- The ventrogluteal site has the strongest clinical evidence for lower pain and fewer complications among IM injection sites, per Cocoman and Murray (2008, British Journal of Nursing).
- The vastus lateralis is not anatomically more nerve-dense than other IM sites. Quad injection pain is more likely caused by muscle tension, post-injection activity, and technique errors.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The ventrogluteal site has the strongest clinical evidence for lower pain and fewer complications among IM injection sites, per Cocoman and Murray (2008, British Journal of Nursing).
- The vastus lateralis is not anatomically more nerve-dense than other IM sites. Quad injection pain is more likely caused by muscle tension, post-injection activity, and technique errors.
- Deltoid injections are clinically appropriate for volumes of 1mL or less. Larger volumes typically produce more localized soreness at this site.
- Repeated injections at a single site, regardless of location, can cause fibrosis over time. Rotation between approved sites is standard clinical guidance for long-term TRT users.
- The '10% of guys can use quads' figure has no published evidence behind it. Tolerance varies by individual anatomy, needle length, and technique rather than a fixed population percentage.
- Persistent pain, swelling, or palpable nodules at injection sites should be reported to a prescribing provider. These symptoms can indicate lipohypertrophy, fibrosis, or infection risk, none of which are self-manageable.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
HARLEYMEDS.COM · TikTok creator
73.5K views on this video
Testosterone replacement therapy quad injection #Trt #trtgains #trt101 #trtfamily #trttransformation #trtshots #trtshot #trtforlife #trtdays #trtcommunity #trtbeforeandafter #trtlife #trtgainz #trtformen #trtworld #trtnation #lowt #testosterone #testosteronelevels #testosteroneinjection #testosteronecypionate #testosteronegains #testosteronetherapy #testosteroneboosters #testosteroneshots #testosteroneshot #testosteroneshottime #testosteronehealth #testosteroneformen #testosteronecli
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by HARLEYMEDS.COM, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.